Papillary Lesions of the Breast
Authors:
- Marina De BrotMBMarina De Brot
- Frank GoldbergFGFrank Goldberg
- Derek MuradaliDMDerek Muradali
- Frances P. O’mAlleyFOFrances P. O’mAlley
- Anna Marie MulliganAMAnna Marie Mulligan
- 1 April 2012
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 36 (4) , 544-551
Abstract
Classifying papillary lesions of the breast on core biopsy (CB) is challenging. Although traditionally all such lesions were surgically excised, at present, conservative management of benign lesions is being advocated; therefore, accurately classifying papillary lesions on CB is all the more imperative. The extent to which subspecialty training in breast pathology might mitigate such difficulties in diagnosis has not yet been reported. We investigated change in diagnoses from CB to surgical excision according to subspecialist training in breast pathology and interobserver agreement between specialized breast pathologists (BPs) and nonbreast pathologists (NBPs) in classifying these lesions. CBs of 281 papillary lesions from 266 patients diagnosed between 2000 and 2010 were classified by both a BP and NBP into benign, atypical, ductal carcinoma in situ/encapsulated papillary carcinoma, or invasive carcinoma categories. Rates of change in diagnostic category in the surgical excision specimen were calculated on the basis of: (i) the original diagnosis, (ii) diagnosis made by the BP, and (iii) diagnosis made by the NBP. Comparisons were made using the χ2 test. Kappa values were calculated for interobserver agreement. Of 162 lesions with subsequent excision, 90 were originally diagnosed as benign, 38 as atypical, 25 as ductal carcinoma in situ/encapsulated papillary carcinoma, and 9 as invasive on CB. The upgrade rate for benign papillomas to an atypical or malignant lesion on surgical excision was 22.2% according to the original diagnosis. This rate fell to 16.3% when the BP diagnoses were considered, compared with 26.3% for the NBP diagnoses. There was no significant difference between BPs and NBPs in the rate of upgrade from a benign to an atypical/malignant diagnosis, although downgrades from atypical/malignant to benign papillomas were more commonly seen among NBPs (P=0.002). Overall, the BP diagnosis on CB was less likely to differ from the excision diagnosis (P=0.0001). Benign papillomas upgraded on excision were more likely to occur with larger radiologic mass size (P=0.033) compared with those that were not upgraded. Of 8 benign papillomas upgraded to a malignant lesion on excision, 7 were discordant on radiology. Interobserver agreement between BP and NBP diagnoses was in the “fair agreement” range (κ=0.38), with perfect agreement in 66.4% of cases. Correlation between CB and excision diagnoses for breast papillary lesions is significantly greater for BPs than for NBPs. This is largely because of a tendency to overcall atypia or malignancy on CB by NBPs. However, upgrades from benign to atypical or malignant did not significantly differ according to subspecialization. With accurate pathologic assessment and radiologic-pathologic correlation, the upgrade rate of benign papillomas to malignancy can be minimized significantly.Keywords
This publication has 23 references indexed in Scilit:
- Risk Factors for Malignancy in Benign Papillomas of the Breast on Core Needle BiopsyWorld Journal of Surgery, 2009
- Risk Factors Associated with Conversion from Nonmalignant to Malignant Diagnosis After Surgical Excision of Breast Papillary LesionsAnnals of Surgical Oncology, 2009
- Management of Intraductal Papillomas of the Breast: An Analysis of 129 Cases and Their OutcomeAnnals of Surgical Oncology, 2009
- Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsyCancer, 2009
- Papillary lesions of the breast diagnosed by core needle biopsy: 71 cases with surgical follow-upThe American Journal of Surgery, 2009
- Papillary lesions of the breast: selected diagnostic and management issuesHistopathology, 2007
- Clinicopathologic features of papillary lesions on core needle biopsy of the breast predictive of malignancyThe American Journal of Surgery, 2007
- Observer variability in the histopathological reporting of core biopsies of papillary breast lesions is reduced by the use of immunohistochemistry for CK5/6, calponin and p63Histopathology, 2005
- Association of breast cancer with papillary lesions identified at percutaneous image-guided breast biopsyThe American Journal of Surgery, 2004
- Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: histologic predictors of malignancyLaboratory Investigation, 2004